These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2841581)

  • 21. Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src).
    Smart JE; Oppermann H; Czernilofsky AP; Purchio AF; Erikson RL; Bishop JM
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6013-7. PubMed ID: 6273838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity.
    Buss JE; Kamps MP; Gould K; Sefton BM
    J Virol; 1986 May; 58(2):468-74. PubMed ID: 3009860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 90,000-dalton binding protein common to both steroid receptors and the Rous sarcoma virus transforming protein, pp60v-src.
    Schuh S; Yonemoto W; Brugge J; Bauer VJ; Riehl RM; Sullivan WP; Toft DO
    J Biol Chem; 1985 Nov; 260(26):14292-6. PubMed ID: 2414293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation.
    Cross FR; Garber EA; Pellman D; Hanafusa H
    Mol Cell Biol; 1984 Sep; 4(9):1834-42. PubMed ID: 6092942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodinated fatty acids as probes for myristate processing and function. Incorporation into pp60v-src.
    Peseckis SM; Deichaite I; Resh MD
    J Biol Chem; 1993 Mar; 268(7):5107-14. PubMed ID: 8444887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin.
    Parsons SJ; McCarley DJ; Ely CM; Benjamin DC; Parsons JT
    J Virol; 1984 Aug; 51(2):272-82. PubMed ID: 6205164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability.
    Wang HC; Parsons JT
    J Virol; 1989 Jan; 63(1):291-302. PubMed ID: 2535735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphotyrosine-containing 120,000-dalton protein coimmunoprecipitated with pp60v-src from Rous sarcoma virus-transformed mammalian cells.
    Lau AF
    Virology; 1986 May; 151(1):86-99. PubMed ID: 2421483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of Rous sarcoma virus transformation mutants with differing tyrosine kinase activities to study the relationships between vinculin phosphorylation, pp60v-src location and adhesion plaque integrity.
    Kellie S; Patel B; Wigglesworth NM; Critchley DR; Wyke JA
    Exp Cell Res; 1986 Jul; 165(1):216-28. PubMed ID: 3011478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockage of morphological transformation of chick embryo fibroblasts infected with Rous sarcoma virus by N-myristoyl glycinal diethylacetal in vitro.
    Shoji S; Matsunaga M; Tsujita R; Kubota Y
    Biochem Int; 1989 Mar; 18(3):509-18. PubMed ID: 2548507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins.
    Reynolds AB; Kanner SB; Wang HC; Parsons JT
    Mol Cell Biol; 1989 Sep; 9(9):3951-8. PubMed ID: 2476666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forms of pp60v-src isolated from Rous sarcoma virus-transformed cells.
    Collett MS; Belzer SK
    J Virol; 1987 May; 61(5):1593-601. PubMed ID: 2437320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to an NH2-terminal myristoyl glycine moiety can detect NH2-terminal myristoylated proteins in the retrovirus-infected cells.
    Shoji S; Tashiro A; Furuishi K; Takenaka O; Kida Y; Horiuchi S; Funakoshi T; Kubota Y
    Biochem Biophys Res Commun; 1989 Jul; 162(2):724-32. PubMed ID: 2547372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src.
    Kamps MP; Sefton BM
    Mol Cell Biol; 1986 Mar; 6(3):751-7. PubMed ID: 2430174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Rous sarcoma virus transforming protein pp60v-src in Saccharomyces cerevisiae cells.
    Brugge JS; Jarosik G; Andersen J; Queral-Lustig A; Fedor-Chaiken M; Broach JR
    Mol Cell Biol; 1987 Jun; 7(6):2180-7. PubMed ID: 3037349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of avian and viral p60src proteins expressed in yeast.
    Kornbluth S; Jove R; Hanafusa H
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4455-9. PubMed ID: 2440023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.
    Kamps MP; Buss JE; Sefton BM
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4625-8. PubMed ID: 2991884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transit of pp60v-src to the plasma membrane.
    Courtneidge SA; Bishop JM
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7117-21. PubMed ID: 6296817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene.
    Cross FR; Garber EA; Hanafusa H
    Mol Cell Biol; 1985 Oct; 5(10):2789-95. PubMed ID: 2426576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformation by p60src with altered N-terminal sequences.
    Hanafusa H; Garber EA; Hanafusa T
    Princess Takamatsu Symp; 1986; 17():233-40. PubMed ID: 2843496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.